#japanapproval — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #japanapproval, aggregated by home.social.
-
Celltrion has obtained Japanese regulatory approval for its Actemra biosimilar Avtozma, targeting key autoimmune indications and aiming to expand its presence in Japan’s pharmaceutical market.
#YonhapInfomax #Celltrion #Avtozma #Biosimilar #JapanApproval #AutoimmuneDiseases #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82759 -
Celltrion has obtained Japanese regulatory approval for its Actemra biosimilar Avtozma, targeting key autoimmune indications and aiming to expand its presence in Japan’s pharmaceutical market.
#YonhapInfomax #Celltrion #Avtozma #Biosimilar #JapanApproval #AutoimmuneDiseases #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82759 -
Celltrion has obtained Japanese regulatory approval for its Actemra biosimilar Avtozma, targeting key autoimmune indications and aiming to expand its presence in Japan’s pharmaceutical market.
#YonhapInfomax #Celltrion #Avtozma #Biosimilar #JapanApproval #AutoimmuneDiseases #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=82759 -
Yuhan Corporation's lung cancer drug Leclaza combination therapy receives approval as first-line treatment in Japan, marking significant milestone for Korean pharmaceutical industry
#YonhapInfomax #YuhanCorporation #Leclaza #LungCancerDrug #JapanApproval #FirstLineTreatment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56147